- Previous Close
146.91 - Open
145.38 - Bid 59.69 x 1300
- Ask 150.17 x 900
- Day's Range
136.65 - 151.09 - 52 Week Range
123.00 - 257.40 - Volume
605,375 - Avg. Volume
506,867 - Market Cap (intraday)
4.47B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
85.35 - EPS (TTM)
1.76 - Earnings Date May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
226.07
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
www.inspiresleep.comRecent News: INSP
View More
Performance Overview: INSP
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INSP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INSP
View MoreValuation Measures
Market Cap
4.47B
Enterprise Value
4.06B
Trailing P/E
85.83
Forward P/E
69.93
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.71
Price/Book (mrq)
6.48
Enterprise Value/Revenue
5.05
Enterprise Value/EBITDA
62.38
Financial Highlights
Profitability and Income Statement
Profit Margin
6.67%
Return on Assets (ttm)
3.04%
Return on Equity (ttm)
8.48%
Revenue (ttm)
802.8M
Net Income Avi to Common (ttm)
53.51M
Diluted EPS (ttm)
1.76
Balance Sheet and Cash Flow
Total Cash (mrq)
445.55M
Total Debt/Equity (mrq)
4.61%
Levered Free Cash Flow (ttm)
62.72M
Research Analysis: INSP
View MoreResearch Reports: INSP
View MoreRaising target price to $154.00
INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $154.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $148.00
INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $148.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $166.00
INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $166.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $173.00
INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $173.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target